New Award

NEW AWARD: CONGRATULATIONS DR. LEO TSAI!

RECIPIENT: Dr. Leo Tsai TITLE: A Novel Coaxial Deflectable Microcatheter for Rapid Navigation of Tortuous Vessels TYPE OF AWARD: DRIVE INSTITUTION: Beth Israel Deaconess Medical Center TECHNOLOGY TYPE: Therapeutic Device DESCRIPTION: Microcatheters are used to access small vessels throughout the body to treat a wide variety of pathology, from traumatic hemorrhage to tumors. Selection of…

Read More

NEW AWARD: CONGRATULATIONS DR. BEN MATTHEWS

RECIPIENT:  Dr. Ben Matthews TITLE: PR1P, an inhaled novel short peptide for emphysema TYPE OF AWARD:  PILOT INSTITUTION: Boston Children’s Hospital DESCRIPTION:  Emphysema is a chronic progressive pulmonary disease characterized by destruction of alveoli leading to impaired lung function that threatens human health worldwide. Disease progression is due in part to dysregulation of the survival factor Vascular Endothelial Growth Factor (VEGF). …

Read More

NEW AWARD: CONGRATULATIONS DR. MICHAEL SWEENEY!

RECIPIENT:  Dr. Michael Sweeney TITLE: SQPAN TYPE OF AWARD:  PILOT INSTITUTION: Brigham and Women’s Hospital DESCRIPTION:  Cardiac resynchronization therapy (CRT) is an electrical therapy using multi-site cardiac pacing to re-time the asynchronous contraction sequence of the failing heart on a beat-to-beat basis. Worldwide randomized clinical trials have consistently demonstrated that effective CRT induces reverse ventricular remodeling, which is followed…

Read More

NEW AWARD: CONGRATULATIONS DR. PAUL YU!

RECIPIENT:  Dr. Paul Yu TITLE: Molecular Imaging of Dysregulated Angiogenesis in Pulmonary Arterial Hypertension TYPE OF AWARD:  DRIVE INSTITUTION: Brigham and Women’s Hospital DESCRIPTION:   Pulmonary arterial hypertension (PAH) is a disorder of elevated pulmonary vascular resistance characterized by progressive remodeling and obliteration of resistance-determining vessels of the pulmonary circulation. Despite current therapies, transplant-free survival…

Read More

NEW AWARD: CONGRATULATIONS DR. JILL GOLDSTEIN!

RECIPIENT:  Dr. Jill Goldstein TITLE: Development of an electroceutical for treatment of comorbidity between hypertension and major depression. TYPE OF AWARD:  DRIVE INSTITUTION: Brigham and Women’s Hospital DESCRIPTION:  Hypertension is a leading cause of morbidity and mortality in the United States with an overall prevalence of approximately 29%, corresponding to 70 million of Americans. Despite the benefits…

Read More

NEW AWARDS: B-BIC selects five new technologies to award support for commercial development

RECIPIENT:  Dr. Pamela Silver TITLE: A Targeted Erythropoietin-Based Therapeutic TYPE OF AWARD:  DRIVE INSTITUTION: Harvard Medical School DESCRIPTION:  Pamela Silver, PhD., Elliot T and Onie H Adams Professor of Biochemistry and Systems Biology, Harvard Medical School, and a founding member of the Wyss Institute was awarded a DRIVE grant for continued development of a targeted erythropoietin-based therapeutic.  EPO plays…

Read More

NEW AWARDS: B-BIC selects three new technologies to award support for commercial development.

RECIPIENT:  Dr. Ehud Schmidt TITLE: An MRI-Compatible Voltage Device Tracking For Multimodality Electrophysiology TYPE OF AWARD:  PILOT INSTITUTION: Brigham and Women’s Hospital DESCRIPTION:  Ehud Schmidt, PhD, Director of Engineering Physics in the Department of Radiology, Brigham and Women’s Hospital, and Associate Professor at Harvard Medical School receives a Pilot award to develop MRI-compatible voltage device tracking for multimodality…

Read More

NEW AWARDS: B-BIC Supports New Technologies For Commercial Development

RECIPIENT: Dr. Warren Zapol TITLE: Portable and Affordable Lightweight NO Generator TYPE OF AWARD:  DRIVE INSTITUTION: MGH DESCRIPTION:  Warren Zapol, MD, Director of the MGH Anesthesia Center for Critical Care Research at Massachusetts General Hospital, receives a DRIVE award to develop electric nitric oxide generation for medical purposes.  Inhaled nitric oxide (NO) was approved by the FDA…

Read More